A GSK logo is seen on the side of an office building in Poznan, Poland. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

For children with a history of recurrent urinary tract infection (RUTI), the antibiotic nitrofurantoin and cranberry products appeared to decrease the incidence of symptomatic episodes, a ...

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated ...

Gepotidacin is the first new class of oral antibiotics for uUTIs in nearly 30 years, addressing rising drug resistance. Phase 3 trials showed gepotidacin's non-inferiority to nitrofurantoin, with ...

The novel investigational oral antibiotic gepotidacin was efficacious and safe for the treatment of uncomplicated urinary tract infections, with activity against common uropathogens. Gepotidacin, a ...

Earlier research raised concerns about antibiotic use during the first trimester of pregnancy and risk for congenital malformations. In this study, the risk of malformation was higher for infants ...

The US saw several new and expanded FDA indications this year. The top 5 most-read FDA approvals on AJMC.com included 4 novel therapies and 1 expanded indication, reflecting the growing number of ...

Cutaneous adverse drug reactions are a known risk of antibiotic use, but it has been unclear which drug classes carry the highest risk — until now. To crack at this mystery, researchers in Toronto ...